Market Expectation
At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year
If it grows profits by 15.4% per year, the stock should be priced at ₹488.23.
current share price is 11% Undervalued
Past Performance
Last year, profits declined by -21.6%
Profits over past 5 years grew by 26.3% per year
Forecast Range from 3 Analysts
To achieve the most bearish analyst forecast (₹460.00), profits would need to grow by 13.9% per year
To achieve the most bullish analyst forecast (₹485.00), profits would need to grow by 15.2% per year
Industry & Market Trend
Companies in the Pharmaceuticals industry grew profits by 4.4% last year
Companies in the India market grew profits by 30.8% last year
Company has delivered good profit growth of 21.37% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 26.13%
Good Risk to Reward Show
At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year
If it grows profits by 15.4% per year, the stock should be priced at ₹488.23.
current share price is 11% Undervalued
Past Performance
Last year, profits declined by -21.6%
Profits over past 5 years grew by 26.3% per year
Forecast Range from 3 Analysts
To achieve the most bearish analyst forecast (₹460.00), profits would need to grow by 13.9% per year
To achieve the most bullish analyst forecast (₹485.00), profits would need to grow by 15.2% per year
Industry & Market Trend
Companies in the Pharmaceuticals industry grew profits by 4.4% last year
Companies in the India market grew profits by 30.8% last year
Company has delivered good profit growth of 21.37% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 26.13%
Good Risk to Reward Show